ESCRS - PP09.09 - Long-Term Outcomes For Laser Vision Correction Utilising A New Topography- Integrated Wavefront Guided Aberrometer

Long-Term Outcomes For Laser Vision Correction Utilising A New Topography- Integrated Wavefront Guided Aberrometer

Published 2023 - 41st Congress of the ESCRS

Reference: PP09.09 | Type: Free paper | DOI: 10.82333/eb44-ek91

Authors: Stephen Hannan 1 , David Teenan 1 , Jan Venter 1 , Mirna Belovari 1 , Huba Kiss 1 , Dasi Raju 1 , Luca Antico* 1 , Eric Donnenfeld 2 , Steven Dell 3

1Optical Express,Glasgow,United Kingdom, 2Ophthalmology,New York University Medical Centre,New York,United States;Ophthalmology,New York University Medical Centre,New York,United States, 3Ophthalmology, Cataract & Refractive Surgery,Dell Laser Consultants,Austin,United States

Purpose

To evaluate the long-term safety and efficacy outcomes of iDesign 2.0 in patients who underwent laser vision correction.

Setting

Private Refractive Surgery (Optical Express)

Methods

Analysed cohort consists of patients who underwent laser vision correction with iDesign 2.0 ablation and attended a clinical visit at one year postop. Clinical assessments, patient- reported outcomes, and any complications were recorded in an electronic medical record.

Results

The total number of patients included was 319 (622 eyes), with pre-op refractive range of +4.00D to -9.75D with up to 5.25D of astigmatism. At one year postop, 90.9% had MSE within 0.5D of emmetropia. Of these patients, 92.3% had monocular UCDVA of 6/6 or better and 100.0% had 6/12 or better; 96.6% patients had binocular UCDVA of 6/6 or better and 100% had 6/9 or better. One of 622 treated eyes had a loss in BCDVA of >2 lines, 0.2%. 95.6% of patients reported very satisfied or satisfied; 3.1% reported dissatisfied or very dissatisfied at their last assessment.

Conclusions

Long-term follow-up demonstrates this new wavefront guided aberrometer is safe and effective. In addition to high levels of visual acuity gain, patient-reported satisfaction was also high. Incidence of complications was low and in line with other treatment formats. Long-term outcomes from a clinical and patient reported perspective are excellent.